Trial Profile
A Prospective, Multicenter, Randomized, Double-Masked, Parallel-Arm Phase 2b Study Evaluating the Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Travoprost (Primary) ; Timolol
- Indications Glaucoma; Ocular hypertension
- Focus Therapeutic Use
- Sponsors Ocular Therapeutix
- 11 May 2017 According to an Ocular Therapeutix media release,data from this trial was presented at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting (2017).
- 02 May 2017 According to an Ocular Therapeutix media release, data from this study will be presented at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2017.
- 16 Feb 2016 Status changed from active, no longer recruiting to completed, according to an Ocular Therapeutix media release.